study hypothesis: Cellular aging of the egg following ovulation, also known as post-ovulatory aging, is associated with aberrant cortical mechanics and actomyosin cytoskeleton functions. study finding: Post-ovulatory aging is associated with dysfunction of non-muscle myosin-II, and pharmacologically induced myosin-II dysfunction produces some of the same deficiencies observed in aged eggs.
Introduction
Cellular aging of the egg following ovulation, also known as postovulatory aging, can contribute to reduced reproductive success in many different species, including human (Blandau and Young, 1939; Blandau and Jordan, 1941; Guerrero and Lanctot, 1970; Guerrero and Rojas, 1975; Gray et al., 1995; Wilcox et al., 1998; Tarin et al., 2000; Miao et al., 2009; Takahashi et al., 2013) . The normal window of 'fertilizability' of an ovulated mammalian egg is 24 h or less, and changes in the egg occurring during this time account for a limited time period for successful initiation of embryogenesis, either in vivo or by in vitro assisted reproductive technologies (Ducibella, 1998; Miao et al., 2009; . The phenomenon of post-ovulatory aging is a key reason for the use of ovulation prediction methods by couples trying to conceive, with the goal of increasing the chance of an egg being fertilized at its 'prime' (Practice Committee of the American Society for Reproductive Medicine, 2008; Manders et al., 2015) . Post-ovulatory aging in vitro is also an issue for assisted reproductive technologies, such as in instances when ICSI is used in a cycle with fertilization failure after conventional in vitro insemination, known as rescue ICSI (Beck-Fruchter et al., 2014) .
A significant number of cellular, molecular and functional abnormalities are observed in post-ovulatory aged eggs (Miao et al., 2009; Takahashi et al., 2013) . The work here primarily focused on abnormalities in the egg membrane and cortex associated with post-ovulatory aging. Egg membrane receptivity to sperm is altered, with aged eggs being less able to support sperm -egg fusion and slower to fertilize than young eggs (Wolf and Hamada, 1976; Park et al., 2000; Wortzman and Evans, 2005) . If an aged egg is fertilized, responses to sperm are altered, including abnormal patterns of Ca 2+ release, responses to increased intracellular Ca 2+ and aberrant sperm-induced cortical remodeling and formation of fertilization cones at the site of sperm entry (Jones and Whittingham, 1996; Igarashi et al., 1997; Gordo et al., 2000 Gordo et al., , 2002 Takahashi et al., 2000; Dalo et al., 2008) . Aged eggs also are less able to respond to a fertilizing sperm by converting the egg membrane to a state that is unreceptive to sperm (Wortzman and Evans, 2005) , consistent with studies showing that the incidence of polyspermy increases with delayed mating or increased time after ovulation (Austin and Braden, 1953a, b; Odor and Blandau, 1956; Yanagimachi and Chang, 1961) . This background prompted our investigation of the cytoskeleton and cortical mechanics in aged eggs. We have previously characterized cortical tension in mouse oocytes, metaphase II eggs and early zygotes, identified molecules that mediate cortical tension and characterized consequences of disrupted cortical tension in eggs, including spindle morphology and function (Larson et al., 2010) . Based on this work on oocyte cortical tension, and because post-ovulatory aging has effects on the cell cortex and spindle morphology, we hypothesized that there would be differences in cortical tension between young, healthy eggs and post-ovulatory aged eggs. Indeed, we find that postovulatory aged eggs have reduced cortical tension. We also examined two key regulators of cortical tension in eggs [non-muscle myosin-II and ERM family of proteins; ezrin, radixin and moesin (Larson et al., 2010) ], and we find that aged eggs have reduced levels of the active form of the myosin-II regulatory light chain [phosphorylated MRLC (also known as MYL9) or pMRLC]. This prompted examination of the potential association of abnormalities in aged eggs with myosin-II dysfunction, building on our recent studies of kinases that function upstream from myosin-II, myosin light chain kinase (MLCK) and Mitogen-activated protein kinases 3 and 1 (MAPK3 and MAPK1; also known as extracellular signal-regulated kinases ERK1 and ERK2, respectively) (McGinnis et al., 2015) . This is particularly significant to post-ovulatory aged eggs, which have reduced MAPK3/1 activity (Xu et al., 1997) . Here, we examine aspects of a model in which MAPK3/1 regulates MLCK and thus pMRLC levels and cortical tension, and how this can relate to the pathophysiology of post-ovulatory aging. Work here shows that inhibition of MLCK produces several of the same effects as post-ovulatory aging does. Additionally, we examine one of the best known features of postovulatory aging, propensity to undergo parthenogenetic egg activation. This tendency for parthenogenesis with post-ovulatory aging is linked in part with the reduced MAPK3/1 activity in aged eggs, as treating young eggs with the inhibitor of the MAPK3/1 pathway, U0126, can induce parthenogenetic activation (Yanagimachi and Chang, 1961; Whittingham and Siracusa, 1978; Xu et al., 1997; Phillips et al., 2002b; Tong et al., 2003) . Treatment of young eggs with the MLCK inhibitor ML-7 has a comparable parthenogenetic effect (McGinnis et al., 2015) . Here, we demonstrate that age-related parthenogenesis can be partially rescued through an approach that also prevents parthenogenesis induced by inhibition of MAPK3/1 or MLCK. Taken together, these data provide evidence for a connection between post-ovulatory aging and myosin-II dysfunction.
Materials and Methods

Ethical approval
All work involving animals was conducted with approval from the Johns Hopkins University Animal Care and Use Committee.
Collection and manipulations of young and post-ovulatory aged metaphase II eggs
Metaphase II-arrested eggs were collected from the oviducts of 6-to 8-week-old superovulated CF1 mice (Harlan, Indianapolis, IN, USA) as previously described (Wortzman and Evans, 2005; Dalo et al., 2008) . Mice were injected with pregnant mare serum gonadotrophin (PMSG, Calbiochem, supplied by Millipore, Darmstadt, Germany), followed by human chorionic gonadotrophin (hCG, Sigma, St Louis, MO, USA) 48 h later. Eggs collected at 13 -14 h post-hCG are referred to as 'young eggs', and eggs collected at 21 -22 h post-hCG are referred to as 'aged eggs'. The post-hCG times for egg collection were based on previous studies on aging in mouse eggs (Xu et al., 1997; Abbott et al., 1998) as well as our own previous studies of post-ovulatory aging (Wortzman and Evans, 2005; Dalo et al., 2008) ; mice ovulate at 12 h post hCG-injection, thus the aged eggs used here collected at 21 h post-hCG have been aging in the oviduct for 9 h prior to collection.
Cumulus cells were removed from eggs by brief incubation (,5 min) in Whitten's medium (Whitten, 1971) [109.5 mM NaCl, 4.7 mM KCl, 1.2 mM KH 2 PO 4 , 1.2 mM MgSO 4 , 5.5 mM glucose, 0.23 mM pyruvic acid, 4.8 mM lactic acid hemicalcium salt; with 7 mM NaHCO 3 and 15 mM HEPES (hereafter referred to as WH for 'Whitten's-HEPES'), containing 30 mg/ml BSA (Albumax I from Gibco-BRL, Gaithersburg, MD, USA) and 0.025% Type IV-S hyaluronidase (Sigma)]. For experiments using zona pellucida-free eggs, zona pellucida removal was performed by brief incubation ( 10 s) in acidic culture medium compatible buffer (10 mM HEPES, 1 mM NaH 2 PO 4 , 0.8 mM MgSO 4 , 5.4 mM KCl, 116.4 mM NaCl, pH 1.5). Eggs then recovered for 60 min in Whitten's medium containing 22 mM NaHCO 3 (hereafter referred to as WB for 'Whitten's-Bicarbonate') and 15 mg/ml BSA. Eggs were cultured at 378C in a humidified atmosphere of 5% CO 2 in air.
Treatment of young eggs with the MLCK inhibitor ML-7 [1-(5-Iodonaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine hydrochloride, which inhibits MYLK and the skeletal muscle form, MYLK2] was performed as previously described (Matson et al., 2006; Larson et al., 2010; McGinnis et al., 2015) . ML-7 (Sigma) was prepared as a 10 mM stock in DMSO, and used at 15 mM based on previous dose-dependence studies (Matson et al., 2006) . DMSO was used as a solvent control. In vitro fertilization (IVF) of control and ML-7-treated zona pellucida-free young eggs was performed as described (McAvey et al., 2002) with the following modifications. Cauda epididymal sperm was prepared from CD1 retired breeders (Harlan) by swim-up as previously described (Gardner et al., 2007) . Sperm were cultured for a total of 2.5 -3 h in WB medium supplemented with 15 mg/ml BSA (Albumax I), for capacitation and spontaneous acrosome exocytosis. Zona pellucida-free eggs were treated with 15 mM ML-7 (or the solvent control, DMSO) for 1 h prior to insemination. Culture and IVF in the presence of ML-7 was carried out in WB/PVA medium without mineral oil overlay, using four-well Nunclon D-treated plates (Fisher Scientific, Pittsburgh, PA, USA). ML-7-treated and DMSO control eggs were inseminated by adding the appropriate amount of capacitated sperm stock to the 300 ml of WB/ PVA, also containing either 0.5% DMSO or 15 mM ML-7 (30-40 eggs per well in the Nunclon D-treated plate). Sperm motility in ML-7-containing culture medium was indistinguishable from that in control medium. Eggs were cultured with 50 000 sperm/ml for 1.5 h, then washed to remove loosely attached sperm, then fixed in 3.7% paraformaldehyde in PBS and stained with 4 ′ 6'-diamidino-2-phenylindole (DAPI; details below) to determine the number of sperm fused per egg.
Treatment of aged eggs with the zinc ionophore zinc pyrithione (ZnPT; Sigma) was performed as previously described (Kim et al., 2011; Bernhardt et al., 2012; McGinnis et al., 2015) . Aged eggs were cultured briefly ( 15 min) following hyaluronidase treatment, then treated with 10 mM ZnPT for 10 min, followed by five washes through WB with 0.05% polyvinyl alcohol (WB/PVA). ZnPT-treated aged eggs and untreated control aged eggs were cultured for 2 h, then fixed in 3.7% paraformaldehyde in PBS and stained with DAPI (details below).
Young and aged zona pellucida-free eggs were subjected to micropipette aspiration and the effective tension (T eff ) was calculated as previously described (Larson et al., 2010) .
Immunofluorescence and fluorescence microscopy
Eggs were fixed in freshly prepared 4.0% paraformaldehyde in PBS for 45-60 min, permeabilized in PBS containing 0.1% Triton X-100 and blocked in IF Blocking Solution (PBS containing 0.1% BSA, 0.01% Tween-20, 100 mM Na 3 VO 4 ). Washes and antibody dilutions also used this blocking solution. Primary antibodies used here were anti-pERM (phosphorylated ezrin, radixin, moesin) rabbit polyclonal antibody (catalog #3141, Cell Signaling Technologies, USA; 2 mg/ml, overnight at 48C), anti-pMRLC rabbit polyclonal antibody (catalog #3671; Cell Signaling Technologies; 0.1 mg/ml, overnight at 48C) or anti-pMRLC mouse monoclonal antibody (catalog #3675, Cell Signaling Technologies; 6.7 mg/ml, overnight at 48C). Fluorophore-conjugated secondary antibodies (Jackson Immunoresearch) were used at 10-12 mg/ml. Eggs were mounted in Vectashield mounting medium (Vector Laboratories, USA) supplemented with 1.5 mg/ml DAPI (Sigma).
Eggs were imaged on a Nikon Eclipse fluorescent microscope with a Princeton 5 MHz cooled interlined CCD camera (Princeton Instruments, Inc., Trenton, NJ, USA) and IPLab (Scanalytics, Fairfax, VA, USA) or iVision (BioVision, Exton, PA, USA) software. For comparisons of young and aged eggs, the same exposure time was used in capturing all images in each experiment. These standard exposure times were calculated by imaging 10 -15 representative young eggs and averaging the exposure times, which were determined by adjusting the exposure time estimated by the software until all saturation indicators were gone and the live image was consistent with the appearance of the egg when viewed through the eyepiece. Images of eggs here were taken at a variety of focal planes to optimize viewing of the egg region (e.g. amicrovillar domain) and protein of interest.
Immunoblotting
Egg lysates were prepared in 2× SDS -PAGE sample loading buffer, boiled and then separated on a 10 or 12.5% SDS -polyacrylamide gel, and transferred to an Immobilon membrane (Millipore, Billerica, MA, USA). For each experiment, the same number of eggs was loaded in all lanes (25 eggs per lane for ERM blots; 25 or 50 eggs per lane for pERM blots; 90 eggs per lane for MRLC and pMRLC blots). Membranes were blocked in Tris-buffered saline with 0.05% Tween-20 (TBS-T) with 10% cold water fish gelatin (Sigma), then incubated overnight at 48C with primary antibody diluted in TBS-T with 5% BSA [anti-ERM (18 ng/ml; catalog #3142, Cell Signaling Technology); anti-pERM (18 ng/ml; catalog #3141; Cell Signaling Technology); anti-MRLC (10 ng/ml; catalog # 3671, Cell Signaling Technology) or anti-pMRLC (50 ng/ml; catalog #3672; Cell Signaling Technology)], followed by goat antirabbit immunoglobulin G (IgG) horseradish peroxidase-conjugated secondary antibody (Jackson Immunoresearch Laboratories, West Grove, PA, USA). Blots were developed using SuperSignal West Pico Chemiluminescent Substrate (Thermo, Rockford, IL, USA) and exposed to X-ray film (Research Products International Corporation; Mount Prospect, IL, USA). Films were scanned and analyzed using ImageJ software (http://rsb.info.nih.gov/ij/) as we have done previously (McGinnis et al., 2015) . For each blot, an appropriate exposure time was chosen so that no lane was overexposed. The rectangular selection tool was used to select each band and peak intensity was determined. The area under each peak was calculated as a measure of band intensity. Band intensities were recorded as the mean value in arbitrary units (A.U.)+standard error of the mean for each group.
Scanning electron microscopy
Unfertilized and fertilized control and ML-7 treated eggs were prepared and viewed using an FEI Quanta 200 Environmental Scanning Electron Microscope with low-vacuum scanning electron microscopy (LVSEM) mode as previously described (Dalo et al., 2008; Kryzak et al., 2013) . Zona pellucida-free eggs were treated with 15 mM ML-7 (or DMSO) for 1 h prior to fixation, or were inseminated for 1.5 or 2.5 h, then fixed.
Statistical analyses
For comparing T eff measurements between young and aged eggs, the MannWhitney U-test was used. For evaluating immunoblot band intensity, a twoMyosin-II abnormalities in post-ovulatory aged eggs tailed Student t-test was used when comparing ERM, MRLC and pMRLC levels in young and aged eggs; one-way ANOVA with Fisher's protected least significant difference post hoc test was used for comparisons of pERM of young eggs, aged eggs and spontaneously activated aged eggs. x 2 tests or Fisher's exact test was used to compare extents of spontaneous activation, fertilization, polyspermy and abnormal pERM or pMRLC localization between young and aged eggs, or control and ML-7-treated eggs. Analyses were performed using StatView or GraphPad software (USA).
Results
Effective cortical tension (T eff ) in post-ovulatory aged eggs
Given the abnormalities that develop in the egg cortex and cytoskeleton with post-ovulatory aging, we hypothesized that the effective cortical tension (T eff ) would be altered in aged eggs. Micropipette aspiration analyses revealed that cortical tension in both the microvillar domain (to which sperm bind and fuse; Fig. 1A ) and the amicrovillar domain (which sequesters the metaphase II spindle; Fig. 1A ) was significantly lower in post-ovulatory aged eggs when compared with young eggs (P , 0.0001; Fig. 1B and C). Young and aged eggs had lower T eff in the microvillar domain when compared with the amicrovillar domain, as previously described for normal metaphase II eggs (Larson et al., 2010) . The reduced tension in aged eggs also was consistent with observations that aged eggs appeared to be more sensitive to pipette aspiration, based on the observation that aged eggs would lyse more easily when suction pressure was applied when compared with young eggs.
Ezrin-radixin -moesin proteins and myosin regulatory light chain in post-ovulatory aged eggs
Upon finding that post-ovulatory aged eggs have abnormal cortical tension, we examined proteins implicated in regulating cortical tension, non-muscle myosin-II and ezrin -radixin -moesin proteins (ERMs) (Larson et al., 2010) , in aged eggs. Myosin-II is a hexamer, with two heavy chains, two regulatory light chains and two essential light chains. Myosin-II activity is regulated in part by phosphorylation of its regulatory light chain (MRLC); this phosphorylation increases the actin-activated ATPase activity and promotes assembly of myosin-II bipolar thick filaments (Vicente-Manzanares et al., 2009). The ERM family of proteins (ezrin, radixin and moesin) mediates cytoskeletal-membrane interactions (Bretscher et al., 2002; Fehon et al., 2010) . Active phospho-ERMs (pERM) are generated by phosphorylation of a conserved threonine residue in the C-terminal domain that stabilizes a conformation change, allowing interaction with actin filaments through the C-terminal domain and with the membrane through the N-terminal domain (Bretscher et al., 2002; Niggli and Rossy, 2008; Fehon et al., 2010) . Dominant-negative disruption of ERM function or inhibition of MLCK reduced cortical tension in metaphase II eggs (Larson et al., 2010) . In young metaphase II eggs, pERM is localized in the microvillar domain ( Fig. 2A) and pMRLC is in the amicrovillar domain, with enrichment at the boundary of the amicrovillar domain (Fig. 2E, asterisks) (Larson et al., 2010) . In the majority of aged eggs (48/72), pERM was observed in the microvillar domain (Fig. 2B ), similar to young eggs (89/89; Fig. 2A) . A subset of aged eggs (24/72) had subtle abnormalities in pERM localization (enrichment of pERM at the junction between the amicrovillar and microvillar domains; Fig. 2C ; asterisks) and/or cell morphology [protruding amicrovillar domain, shown with anti-pERM staining in Fig. 2D (arrowhead), but more evident with pMRLC staining in Fig. 2H and I]. Abnormalities in pMRLC were observed in 85% of aged eggs (111/130). These pMRLC abnormalities were reduced anti-pMRLC signals with amicrovillar localization ( Fig. 2G ; 30/130 eggs), and abnormal localization of pMRLC with aberrant amicrovillar morphology (81/130 eggs), including a protruding amicrovillar domain ( Fig. 2H and I ; arrowhead), uneven pMRLC distribution around the boundary of the amicrovillar domain ( Fig. 2I) and patchy pMRLC over the amicrovillar domain (Fig. 2J) .
Consistent with these immunofluorescence studies, immunoblot analyses revealed that pMRLC levels in aged eggs were reduced to 30% the levels of pMRLC in young eggs (P ¼ 0.0062; Fig. 3B and D) . Control blots with anti-MRLC and anti-ERM antibodies showed that the levels of these proteins are not significantly different ( Fig. 3C and G) . Given that pERM levels are increased in early zygotes (Larson et al., 2010) , and that postovulatory aged eggs are prone to undergo parthenogenetic egg activation (Yanagimachi and Chang, 1961; Xu et al., 1997), we also examined pERM levels in aged eggs that showed obvious signs of parthenogenetic activation. These spontaneously activated aged eggs had increased pERM levels when compared with young eggs (P ¼ 0.0153; Fig. 3F and H) . The pERM protein levels between young eggs to un-activated postovulatory aged eggs, and between un-activated post-ovulatory aged eggs to spontaneously activated post-ovulatory aged eggs were not statistically significantly different (P ¼ 0.2054 and 0.1006, respectively).
Analysis of parthenogenetic egg activation associated with post-ovulatory aging
Given that post-ovulatory aged eggs had reduced pMRLC levels and cortical tension (Figs 1-3) , we examined the potential association of abnormalities in aged eggs with myosin-II dysfunction in light of our recent studies of MAPK3/1 and MLCK in mouse eggs (McGinnis et al., 2015) . MAPK3/1 (also known as ERK1/2) is regulated by the upstream kinases mitogen/extracellular signal-regulated kinases 1 and 2 (MEK1 and MEK2; also known as mitogen-activated protein kinase kinase 1 and mitogen-activated protein kinase kinase 2, respectively) (Fig. 4A) . MAPK3/1 functions upstream of MLCK in certain cell types (Klemke et al., 1997; Nguyen et al., 1999) (Fig. 4A) , and consistent with this, we showed that eggs treated with the MEK1/2 inhibitor U0126 have reduced pMRLC levels and cortical tension, as do eggs treated with the MLCK inhibitor ML-7 (Larson et al., 2010; McGinnis et al., 2015) (summarized in Fig. 4B ). MAPK3/1 activity also helps maintain metaphase II arrest; U0126-treated eggs are prone to undergo parthenogenetic activation ( , and we also recently showed that ML-7 treatment of eggs produces a similar effect (McGinnis et al., 2015) . Interestingly, postovulatory aged eggs have numerous similarities to eggs treated with U0126 or ML-7 (Fig. 4B) : reduced MAPK3/1 activity (Xu et al., 1997) , reduced pMRLC (Fig. 3B) , reduced cortical tension (Fig. 1) and increased propensity for parthenogenetic activation (Yanagimachi and Chang, 1961; Xu et al., 1997) .
With this foundation, we examined parthenogenetic egg activation in aged eggs. In studies here, 35% of freshly collected aged eggs showed signs of parthenogenetic activation (i.e. assessed shortly after isolation from oviducts, eggs showed signs of progression to anaphase or telophase II, or completion of meiosis II with emission of the second polar body). In contrast, 99% of freshly collected control young eggs were in metaphase II (Fig. 4C) . We additionally tested the hypothesis that post-ovulatory aging-associated parthenogenesis could be rescued by treatment with the zinc ionophore, zinc pyrithione (ZnPT), which increases zinc levels in eggs and other cell types (Bernhardt et al., 2012) . ZnPT-mediated prevention of egg activation has been demonstrated for parthenogenetic egg activation induced by SrCl 2 , U0126 or ML-7 (Kim et al., 2011; Bernhardt et al., 2012; McGinnis et al., 2015) ; the mechanism of this prevention is thought to be maintenance of sufficient levels of intracellular zinc for inhibition of the anaphase-promoting complex (APC) through EMI2 (endogenous meiotic inhibitor 2, also known as FBXO43) (Suzuki et al., 2010) . In these experiments, aged eggs were collected, treated with 10 mM ZnPT for 10 min (or the solvent control DMSO), then cultured for 2 h. After this 2 h of culture, 71% of control aged eggs underwent parthenogenesis, whereas only 41% aged eggs that were treated with ZnPT showed signs of Myosin-II abnormalities in post-ovulatory aged eggs metaphase II exit ( Fig. 4D ; statistically significantly different from the extent of parthenogenesis in control aged eggs, P ¼ 0.003). Taken together, this shows that propensity for parthenogenesis is a feature of post-ovulatory aged eggs, is recapitulated by U0126 treatment or ML-7 treatment (McGinnis et al., 2015) and is rescued in U0126-treated young eggs, ML-7-treated young eggs and aged eggs by treatment with ZnPT [ Fig. 4D and McGinnis et al. (2015) ].
Analysis of myosin-II dysfunction and egg membrane features associated with post-ovulatory aging
In addition to the increased propensity for parthenogenetic egg activation, post-ovulatory aged eggs have abnormalities in membrane topography, reduced ability to support sperm-egg interaction and reduced ability to establish the membrane block to polyspermy (Wortzman and Evans, 2005; Dalo et al., 2008 ) (see also Fig. 4B ). Given that these aspects of egg function could be impacted by myosin-II and that aged eggs have myosin-II-associated abnormalities (Figs 1-3) , we tested the hypothesis that myosin-II disruption via ML-7-mediated inhibition of MLCK would produce some of the same defects as postovulatory aging. Treatment of young eggs with 15 mM ML-7 reduces pMRLC levels and cortical tension to a similar extent as observed here in post-ovulatory aged eggs collected at 22 h post-hCG (Larson et al., 2010; McGinnis et al., 2015) . We examined fertilization and membrane topography in ML-7-treated young eggs, to ascertain if ML-7-mediated disruption of myosin-II function produced similar defects as observed in post-ovulatory aged eggs.
IVF assays were performed with zona pellucida-free ML-7-treated young eggs, in which eggs were pre-treated with 15 mM ML-7 (or the solvent control DMSO) for 1 h, then inseminated for 1.5 h (Fig. 4E) . ML-7 treatment was associated with reduced fertilization, with 35% (177/512) ML-7-treated eggs remaining unfertilized after 1.5 h of co-culture with capacitated sperm, when compared with only 2% (9/429) DMSO-treated eggs being unfertilized (P , 0.0001). Interestingly, in the subset of eggs that were fertilized, polyspermy was increased in the ML-7 treatment group, with 75% (252/335) ML-7-treated fertilized eggs being polyspermic versus 58% (243/420) DMSO-treated fertilized eggs (P , 0.0001). The extent of polyspermy also was higher in ML-7-treated eggs, with 36% of ML-7-treated fertilized eggs having five or more sperm fused (120/335), when compared with 10% of control fertilized eggs (42/420).
These fertilization outcomes prompted us to examine membrane topography in ML-7-treated eggs by LVSEM, and to compare these results with our previous LVSEM studies of post-ovulatory aged eggs (Dalo et al., 2008) . Control eggs showed the well-characterized microvillar and amicrovillar domains (Fig. 5A , shown schematically in Fig. 1A ) (Eager et al., 1976; Nicosia et al., 1978; Longo and Chen, 1985) . In ML-7-treated eggs, amicrovillar domains appeared either to be largely similar to control eggs ( Fig. 5B ; observed in 4/7 eggs for which we had a sufficient view of the amicrovillar domain to assess), or were distended ( Fig. 5C ; observed in 3/7 eggs). This was consistent with analyses of aged eggs using LVSEM or phalloidin to examine F-actin (Wortzman and Evans, 2005; Dalo et al., 2008) , and with immunofluorescence studies here, with some aged eggs appearing to have distended amicrovillar domains ( Fig. 2H and I) . Additionally, ML-7-treated eggs had crater-like structures on the egg surface (Figs 5D and 6D and F; observed in 17/19 unfertilized eggs, 24/24 eggs fixed at 1.5 h post-insemination and 11/11 eggs fixed at 2.5 h post-insemination). Similar crater-like structures were observed in post-ovulatory aged eggs (Dalo et al., 2008) .
Fertilized ML-7-treated eggs had abnormal sperm-induced membrane remodeling, which also was observed in aged eggs (Dalo et al., 2008) . Normal fertilization leads to the formation of a fertilization cone at the site of sperm entry into the egg, with a protruding amicrovillar patch developing over the sperm DNA [control eggs in Fig. 6A and B; see also (Lopata et al., 1980; Maro et al., 1984) or our previous LVSEM studies (Dalo et al., 2008; Kryzak et al., 2013) ]. In ML-7-treated fertilized eggs, there was little to none of this membrane remodeling at sites of sperm entry (Fig. 6C -F) . Small amicrovillar patches were observed in some ML-7-treated eggs ( Fig. 6C ; in 10/24 ML-7 treated eggs fixed at 1.5 h post-insemination, in 2/11 ML-7-treated eggs fixed at 2.5 h 4) ; E and G, anti-ERM (n ¼ 4); F and H, anti-pERM (n ¼ 3)]. MRLC levels were comparable in young and aged eggs (A and C). Aged eggs had lower levels of pMRLC than young eggs (B and D; P ¼ 0.0062). ERM levels were comparable between young and aged eggs (E and G). pERM levels between young eggs to un-activated postovulatory aged eggs, and between un-activated post-ovulatory aged eggs to spontaneously activated post-ovulatory aged eggs were not statistically significantly different (P ¼ 0.2054 and 0.1006, respectively), in contrast to pERM levels between spontaneously activated aged eggs and young eggs (P ¼ 0.0153). (2015)], noting that MAPK3/1 activity is inhibited with U0126, an inhibitor of the upstream activating kinases MEK1/2 and that MLCK activity is inhibited by ML-7. (B) Data from previous studies (Yanagimachi and Chang, 1961; Whittingham and Siracusa, 1978; Xu et al., 1997; Phillips et al., 2002b; Tong et al., 2003; Larson et al., 2010; McGinnis et al., 2015) , and also puts new data presented here in context with these other data; new data are indicated with bold and brighter color font, and the associated figure cited. (C and D) Analysis of parthenogenetic egg activation in freshly collected ovulated eggs (i.e. assessed shortly after isolated from oviducts; C, n ¼ 12 experiments), and in ovulated eggs cultured for 2 h after isolation from oviducts (D; n ¼ 4 experiments). For the studies shown in D, aged eggs were either left untreated and cultured for 2 h, or were treated with zinc pyrithione (ZnPT) for 10 min prior to culture for an additional 2 h. The extent of parthenogenesis in the ZnPT-treated group versus the untreated groups is statistically significantly (P ¼ 0.003). (E) Outcomes from IVF of young zona pellucida-free eggs that were pre-treated with 15 mM ML-7 (or the solvent control DMSO) for 1 h, then inseminated for 1.5 h with 50 000 sperm/ml. The x-axis indicates number of sperm fused and the y-axis shows the percentage of eggs with the indicated number of sperm fused (n ¼ 18 experiments). The overall distributions between the control and the ML-7-treated group are statistically significantly different (P , 0.0001); other differences are noted in the main text. The values for average number of sperm fused per egg (+ SEM) were 2.29 + 0.083 sperm fused per DMSO-treated egg (n ¼ 429 eggs), and 2.61 + 0.14 sperm fused per ML-7 treated egg (n ¼ 512 eggs) (P ¼ 0.0613). For the subset of fertilized eggs, these values were 2.34 + 0.083 sperm fused per DMSO-treated fertilized egg (n ¼ 420 eggs), and 3.99 + 0.16 sperm fused per ML-7-treated egg (n ¼ 335 eggs) (P , 0.0001).
Myosin-II abnormalities in post-ovulatory aged eggs post-insemination). These amicrovillar patches were considerably smaller than those in control eggs fixed at the same post-insemination times [e.g. compare with Fig. 6A and B here and other studies (Dalo et al., 2008; Kryzak et al., 2013) ]. In a portion of ML-7-treated eggs, no amicrovillar patches were observed at sperm entry sites (12/24 eggs fixed at 1.5 h post-insemination and in 7/11 eggs fixed at 2.5 h postinsemination). Fertilized ML-7-treated eggs also did not complete meiotic cytokinesis, in agreement with previous studies (Matson et al., 2006) . Two amicrovillar patches are observed over the maternal DNA, likely in anaphase or telophase II, but no second polar body emission, likely due to inhibition of spindle rotation and cytokinesis (Fig. 6C ). Figure 7 summarizes the findings in this study and puts these results in context with other phenomena associated with post-ovulatory aging.
Discussion
One major effect revealed by the studies here is the decrease in pMRLC levels and cortical tension in aged eggs. This augments other studies demonstrating how various cytoskeletal elements are affected by post-ovulatory aging (e.g. Eichenlaub-Ritter et al., 1986; Webb et al., 1986; George et al., 1996; Wortzman and Evans, 2005; Sun et al., 2012) ; reviewed in Miao et al. (2009) and Takahashi et al. (2013) . Other changes occur in the aged eggs cortex as well, including reduction in levels of NLRP5 and MSY2 (Trapphoff et al., 2016) ; because these proteins are crucial for egg/embryo health (Medvedev et al., 2011; Tong et al., 2000) , the loss of cortical NLR family, pyrin domain containing 5 (NLRP5) and Y-box Protein 2 (YBX2, also known as MSY2) is a possible contributor to poor reproductive outcomes when fertilization occurs at later times after ovulation. Our previous work has demonstrated the relevance of cortical tension to normal egg function (Larson et al., 2010; McGinnis et al., 2015) , and interestingly, some of the changes that we have observed in eggs with reduced tension Figure 5 Membrane topography in control and ML-7-treated young, unfertilized eggs. LVSEM was used to examine control eggs (A) and ML-7-treated fertilized eggs (B-D). As shown previously (Eager et al., 1976; Nicosia et al., 1978; Longo and Chen, 1985) , control eggs have two distinct surface domains, the microvillar and amicrovillar domains. In ML-7-treated eggs, the amicrovillar domain either seemed mostly normal (B; 4/7 eggs for which we had a sufficient view of the amicrovillar domain), or was somewhat distended (Panel C; 3/7 eggs). The microvillar domain of 17 out of 19 ML-7-treated eggs analyzed showed varying extents of crater-like structures on the egg surface, shown in higher magnification in D (see also Fig. 6 for these features in fertilized ML-7-treated eggs). Scale bars equal 5 mm in A -C, and 2 mm in D.
are similar to those observed in post-ovulatory aged eggs, including spindle abnormalities and digyny (Tarin et al., 2000; Miao et al., 2009; Takahashi et al., 2013; Bianchi et al., 2015; Trapphoff et al., 2016) . As we discuss more below, altered cortical tension and cytoskeletal function in aged eggs also may impact the propensity for parthenogenetic egg activation, potentially through dysregulation of membrane ion channels (McGinnis et al., 2015) .
The altered myosin-II function in aged eggs appears to be an underlying cause of the deficiency in sperm-induced cortical and membrane remodeling leading to fertilization cone formation. The SEM studies here demonstrate that ML-7-treated young eggs have similar defects in fertilization cone formation as do aged eggs (Dalo et al., 2008) , also consistent with related studies (Deng et al., 2005) . In addition to the likely contribution of reduced MAPK3/1 and MLCK activities, another potential effector of Figure 6 Membrane topography and sperm-induced surface remodeling in control and ML-7-treated young fertilized eggs. LVSEM was used to examine control fertilized eggs (A and B, fixed at 1.5 or 2.5 h post-insemination, respectively) and ML-7-treated fertilized eggs (C-F; images here show ML-7-treated eggs fixed at 1.5 h post-insemination). In control eggs, amicrovillar patches develop over the site of sperm entry and develop into elevated fertilization cones (A and B; observed in all eggs, n ¼ 15 fixed at 1.5 h, n ¼ 20 fixed at 2.5 h). In contrast, only small amicrovillar patches are in ML-7-treated eggs (C; observed in 10/24 eggs fixed at 1.5 h post-insemination, in 2/11 eggs fixed at 2.5 h post-insemination), or no amicrovillar patches are observed (D-F; observed in 12/24 eggs fixed at 1.5 h post-insemination and in 7/11 eggs fixed at 2.5 h post-insemination). Arrowheads mark sites of sperm entry. Scale bars in A -C and E equal 5 mm, and in D and F equal 2 mm. PB2, second polar body in A and B. Asterisks in C mark two amicrovillar patches over maternal DNA that has exited from metaphase II arrest, but not progressed to polar body emission due to failed spindle rotation, as shown in previous studies (Matson et al., 2006) .
Myosin-II abnormalities in post-ovulatory aged eggs this phenomenon could be the diminished Ca 2+ stores and abnormal Ca 2+ responses to fertilization or fertilization-like stimuli that have been documented in aged eggs (Fig. 7 ) (Jones and Whittingham, 1996; Igarashi et al., 1997; Gordo et al., 2000 Gordo et al., , 2002 Takahashi et al., 2000; Fissore et al., 2002) . Sperm-induced calcium oscillations could be important for fertilization cone formation, since actomyosin-mediated contractions toward the sperm entry site occur in synchrony with calcium oscillations (Ajduk et al., 2011) . ML-7-treated young eggs also show fertilization phenotypes that have been previously observed in aged eggs: reduced membrane receptivity to sperm, and an apparent impaired ability to establish the membrane block to polyspermy (Wolf and Hamada, 1976; Park et al., 2000; Wortzman and Evans, 2005) . These data are consistent with other studies of the membrane block to polyspermy, showing a correlation of defects in sperm-induced cortical remodeling and an impaired ability to establish the membrane block to polyspermy (Kryzak et al., 2013) . Taken together, these studies of ML-7-treated eggs demonstrate how decreased pMRLC levels and actomyosin-based contractility (Figs 1-3 ) could underlie several abnormalities in aged eggs. A previously observed abnormality in aged eggs is an increased susceptibility to parthenogenetic egg activation (Yanagimachi and Chang, 1961; Whittingham and Siracusa, 1978; Xu et al., 1997) . The work here adds to this body of knowledge in two noteworthy ways. First, we report that treatment with ZnPT, which has been shown to increase zinc concentrations in eggs (Bernhardt et al., 2012) , has a partial preventive effect against aged-associated parthenogenesis, as ZnPT treatment does for parthenogenesis induced by either U0126 or ML-7 treatment (McGinnis et al., 2015) . Secondly, the data here combined with other published data (McGinnis et al., 2015) are suggestive of a connection between reduced cortical tension and parthenogenesis, with the possibility that the reduced cortical tension contributes to dysregulation of ion channels (Fig. 7) . Decreased cortical tension is observed in aged eggs, U0126-treated young eggs and ML-7-treated young eggs, and all of these types of eggs are prone to undergo parthenogenesis. In addition, U0126-induced and ML-7-induced parthenogenesis appeared to be partly dependent on extracellular calcium (McGinnis et al., 2015) , raising the possibility that a mechanism underlying the propensity for parthenogenesis in all of these types of eggs could be dysregulation of ion channel(s) (Fig. 7) . Relatively little is known about membrane ion channels playing roles in egg activation and it is likely that multiple channels are involved (Miao et al., 2012; Bernhardt et al., 2015) , but recent studies are starting to provide new clues (Bernhardt et al., 2015; Lee et al., 2015) . The transient receptor potential (TRP) channels are candidate mechanosensitive channels (Plant, 2014) . TRPV3 in eggs mediates Sr 2+ influx in SrCl 2 -induced parthenogenesis (Carvacho et al., 2013) and TRPV3 function has recently been shown to be impaired in mouse eggs treated with an actin-disrupting drug . Further understanding of ion channels in egg activation, including the potential contribution of mechanosensitive channels, will come from future studies. Lastly, several of the events associated with post-ovulatory aging are potentially connected (Fig. 7) . One significant factor in post-ovulatory aging is the accumulation of various reactive oxygen species (ROS) in eggs (Takahashi et al., 2003; , which in turn may affect some of the phenomena reported here. Effects of ROS on parthenogenesis may occur through ROS-mediated suppression of cell cycle regulatory tyrosine kinases such as Cell Division Cycle 25 (CDC25) . ROS can affect numerous signaling pathways, Decreased MLCK was not experimentally ascertained in aged eggs, but is surmised based on studies with the MLCK inhibitor ML-7, here and in other work (Deng et al., 2005; Larson et al., 2010; McGinnis et al., 2015) . Additional kinases can phosphorylate MRLC (Vicente-Manzanares et al., 2009 ).] References for the various phenomena illustrated are as follows: increased ROS (Takahashi et al., 2003; , reduced MAPK3/1 activity (Xu et al., 1997) ; egg membrane and cortex abnormalities (e.g. Eichenlaub-Ritter et al., 1986; Webb et al., 1986; George et al., 1996; Wortzman and Evans, 2005; Sun et al., 2012; reviewed in Miao et al. (2009) and Takahashi et al. (2013) ); reduced Ca 2+ stores (Jones and Whittingham, 1996; Takahashi et al., 2000; Fissore et al., 2002) ; spindle abnormalities (e.g. (Webb et al., 1986; Cecconi et al., 2014) ; reviewed in Miao et al. (2009) , Takahashi et al. (2013) and Trapphoff et al. (2016) ; parthenogenesis (Yanagimachi and Chang, 1961; Whittingham and Siracusa, 1978; Xu et al., 1997) ; possibility of aberrant ion homeostasis with reduced cortical tension (McGinnis et al., 2015) .
including MAPK pathways, although the effects can vary widely depending on the cell type, ROS source, ROS inducer and numerous other variables (Wen et al., 2013) , and how increased ROS may affect MAPK3/1 in eggs is not known. Thus, it is unclear if the decline in MAPK3/1 activity in aged eggs is a downstream effect of the increase in ROS, or a separate pathway in post-ovulatory aging. With regard to cortical tension, reduced cellular stiffness is observed in myoblasts treated with H 2 O 2 (Sun et al., 2014) , consistent with what we observe in aged eggs (Fig. 1) . However, part of the cause of the reduced stiffness in these H 2-O 2 -exposed cells is thought to be reduced pERM (Sun et al., 2014) , differing from studies here of aged eggs (Figs 2 and 3) . The potential connections of oxidative stress in aged eggs and the gamut of deficiencies observed with post-ovulatory aging remain to be fully elucidated. In addition to oxidative stress, reduced MAPK3/1 activity may also be a major contributor to several aging-associated defects. Maintenance of metaphase II arrest (and thus prevention of parthenogenesis) appears to involve MAPK3/1 on multiple levels, including maintaining activation of maturation-promoting factor (MPF) and suppressing the activity of the APC through EMI2 (Phillips et al., 2002b; Verlhac et al., 1994; Miyagaki et al., 2014) . MAPK3/1 also affects, at least indirectly, membrane and cytoskeletal proteins as well. MAPK3/1 regulates the activity of the HCO 3 2 /Cl 2 exchanger (Phillips et al., 2002a; Zhou et al., 2009) , and as we speculate above, potentially other ion channels. Eggs with reduced MAPK3/1 activity have reduced cortical tension and pMRLC (McGinnis et al., 2015) , similar to what was found here with aged eggs, and also what is found in eggs treated with ML-7 (Larson et al., 2010) . This provides an additional potential avenue by which reduced MAPK3/1 activity contributes to parthenogenetic activation (Fig. 7) . These dysfunctions downstream of loss of MAPK3/1 activity can contribute to the reduced quality and viability of aged eggs, providing an increased appreciation of the expanding repertoire of functions MAPK3/1 has, and why MAPK3/1 activity is a key factor in egg health. In summary, the work here characterizes new phenomena associated with post-ovulatory aging, and the data here implicate myosin-II dysfunction as a contributor to the pathophysiology of aged eggs. This extends our understanding of cellular, molecular and functional abnormalities that contribute to why an egg has a limited window of time for successful fertilization and initiation of embryo development.
